David Kim

Associate Vice President at Emalex Biosciences

David Kim serves as the Senior Director of Clinical Operations at Emalex Biosciences. He is responsible for managing all operational aspects of the clinical development program.

Mr. Kim has over 27 years of experience in the pharmaceutical industry, beginning his career at Abbott Laboratories as a scientist. Previously, he served as Associate Director at Takeda, where he led the Clinical team in submission of New Drug Applications (NDAs). He also served as a Director of Clinical Operations at Baxter, where he led the formation of the Clinical Operations team in their Deerfield, IL and Beltsville, MD offices. He served the last seven years as Director of Project Management and Director of Clinical Trial Management at ICON Clinical Research in rare diseases, anti-infectives and oncology therapeutic areas.

Mr. Kim holds a Bachelor of Science degree from the University of Illinois at Urbana-Champaign.

Location

Chicago, United States

Links


Org chart

No direct reports

Teams


Offices


Emalex Biosciences

Emalex Biosciences, LLC is a biopharmaceutical company dedicated to the development of new treatments for rare and orphan neurological conditions. Ecopipam, its first development candidate, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome.


Industries

Employees

11-50

Links